{
    "clinical_study": {
        "@rank": "148112", 
        "arm_group": {
            "arm_group_label": "Pomegranate", 
            "arm_group_type": "Experimental", 
            "description": "The women in this group will drink pomegranate juice"
        }, 
        "brief_summary": {
            "textblock": "Preterm premature rupture of membrane is associated with increased oxidative stress and\n      inflammatory process, enhancing the activity or the availability of antioxidants may\n      modulate the inflammatory response associated with PPROM, thereby reducing oxidative stress\n      and the risk to the fetus.  In this study the investigators  sought to determine the effects\n      of Pomegranate 1. On the patients (maternal and fetal) oxidative stress and inflammation\n      associated with PPROM. 2. On the time interval from PPROM to delivery and on the patients\n      (fetal )Ph and apger scores"
        }, 
        "brief_title": "Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "PPROM", 
        "condition_browse": {
            "mesh_term": [
                "Fetal Membranes, Premature Rupture", 
                "Rupture"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study the investigators sought to determine the effects of Pomegranate 1. On the\n      patients (maternal and fetal )oxidative stress and inflammation associated with PPROM. 2. On\n      the time interval from PPROM to delivery and on the patients (fetal )Ph and apger scores"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pregnant patients\n\n          -  admitted with PPROM\n\n          -  between 24-32 weeks of gestation\n\n        Exclusion Criteria:\n\n          -  Women with contractions\n\n          -  abruption\n\n          -  monochorionic multiple pregnancy\n\n          -  abnormal (non-reassuring) cardiotocogram\n\n          -  meconium-stained amniotic fluid\n\n          -  signs of intrauterine infection\n\n          -  major fetal anomalies\n\n          -  hemolysis\n\n          -  elevated liver enzymes\n\n          -  low platelets (HELLP syndrome); or severe preeclampsia."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "44 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02069587", 
            "org_study_id": "0074-13HYMC"
        }, 
        "intervention": {
            "arm_group_label": "Pomegranate", 
            "intervention_name": "pomegranate", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Pomegranate juice"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PPROM", 
            "PREGNANCY", 
            "POMEGRANATE", 
            "OXIDATIVE STRESS"
        ], 
        "lastchanged_date": "February 20, 2014", 
        "location": {
            "contact": {
                "email": "tomor2304@yahoo.com", 
                "last_name": "Ron Balosesky, MD", 
                "phone": "972509205759"
            }, 
            "facility": {
                "address": {
                    "city": "Hadera", 
                    "country": "Israel", 
                    "zip": "38100"
                }, 
                "name": "Hillel Yaffe Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes", 
        "overall_contact": {
            "email": "tomor2304@yahoo.com", 
            "last_name": "ron beloosesky, M.D", 
            "phone": "011972509205759"
        }, 
        "overall_official": {
            "affiliation": "Hillel Yaffe Medical center technion", 
            "last_name": "ron beloosesky", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Maternal and fetal oxidative stress will be determined by blood tests.", 
                "measure": "Maternal and fetal oxidative stress", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "description": "Maternal blood and umbilical cord blodd will be drawn following delivery and oxidative blood markers inflammatory mediators will be assessed", 
                "measure": "Maternal and fetal oxidative stress", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02069587"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Time interval from PPROM to delivery, respiratory distress syndrome (RDS),  meconium aspiration syndrome,  asphyxia, late onset neonatal sepsis, hypoglycemia, necrotizing enterocolitis, hyperbilirubinemia, intraventricular hemorrhage, periventricular leucomalacia, convulsions, other neurological abnormalities, other complications, intrapartum death, total length of hospital stay and admission, and length of stay on neonatal intensive care unit (NICU).", 
                "measure": "Time interval from PPROM to delivery", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "description": "following birth the time interval from PPROM to delivey will be assessed, also RDS, fetal Ph  and other neonatal complications", 
                "measure": "time interval from PPROM to delivery", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }
        ], 
        "source": "Hillel Yaffe Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hillel Yaffe Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}